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THE RAPID TRANSFORMATION OF HYPERTHYROIDISM TO HYPOTHYROIDISM COMPLICATED 
BY MYASTHENIA GRAVIS 
Iwao Takanami, a Tetsuo Imamuma, 6 Yasuki Yamamoto, a Tatsuya Yamamoto, ~and Susumu Kodaira, a Tokyo, Japan 
Myasthenia gravis (MG) is considered an autoimmune 
disease. Among the other autoimmune disorders that 
complicate MG, hyperthyroidism is the most frequently 
seen. 1 Concerning the effect of thyroid function on myas- 
thenia, findings are conflicting. Some have reported that 
as the hyperthyroidism was treated there was a worsening 
of the MG:'3; others have reported that the condition 
improved] '4 We report a patient with hyperthyroidism 
that was rapidly transformed into hypothyroidism. Com- 
plications of MG occurred uring this transformation. 
A 25-year-old man had excessive sweating and palpita- 
tion since 1989 (when he was 20 years old). A physician 
noted the presence of a struma in October 1992. Labora- 
tory studies in June 1993 revealed the following results: 
free triiodothyronine, 15.0 pg/ml (normal range, 2.5 to 6.0 
pg/ml); free thyroxine, 3.0 mg/ml (normal range, 0.8 to 2.2 
mg/ml); thyroid-stimulating hormone (TSH), 0.05/xIU/ml 
(normal range, 0.3 to 3.9/xIU/ml); thyroglobulin hemag- 
glutination x1600 (normal, <×1000); and microsome 
hemaglutination x 6400 (normal, < × 100). A diagnosis of 
Graves' disease (hyperthyroidism) was confirmed, and 
treatment with 5 mg methimazole was initiated. Diplopia 
and ptosis were first noted in October 1993. Dysphagia 
and weakness in the extremities developed in January 
1994. In March 1994, a diffuse, elastic, soft struma was 
palpated in the anterior neck region. Laboratory studies 
revealed the following results: free triiodothyronine, 3.4 
pg/ml; free thyroxine, 0.57 ng/ml; TSH, 32/.tIU/ml; thyro- 
globulin hemagglutination, ×6400; and microsome hem- 
agglutination, ;425600. TSH-binding inhibitory immuno- 
globulin was 12.2% (normal range, -10% to +10%). 
Thyroid-stimulating antibodies was 240% (normal, <145%). 
Changes in results of thyroid function studies between June 
1993 and this writing are shown in Table I. The anti- 
acetylcholine receptor antibody level was elevated to 3.1 
nmol/L (normal, 0.2 nmol/L). Electomyography showed the 
waning phenomenon after continuous peripheral nerve stim- 
ulation typical of MG. Simultaneous occurrence of hypothy- 
roidism and MG was diagnosed. After admission, methima- 
zole treatment was discontinued, and replacement therapy 
with 25 mg thyroid extract was begun. When the patient 
attained euthyroid status, extended thymectomy was per- 
formed. Many lymphoid follicles, each with a germ center, 
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Table I. Changes in thyroid function by days of 
methimazole therapy 
-7" 30 60 90 150 180 270 
Free T 3 (pg/ml) 15.0 12.0 5.1 3.9 3.9 3.6 3.4 
Free T4 (ng/ml) 3.0 3.83 1.52 0.96 0.96 0.96 0.57 
TSH (/xIU/ml) 0.05 0.05 0.05 1.5 7.2 13 32 
Normal values: Free T3, 2.5-6.0 pg/ml; free T4, 0.8-2.2 hg/dl; TSH, 0.3-3.9 
/zlU/ml. MG symptoms were observed from day 120. Ts, triiodothyronine; 
7"4, thyroxine. 
*Methimazole therapy was started on day 0. Day -7 thus represents 1 
week before the start of therapy. 
were observed histologically. These histologic findings were 
compatible with a diagnosis of MG. Symptoms caused by 
MG subsided after operation. Anti-acetylcholine r ceptor 
antibody, TSH-binding inhibitory immunoglobulin, and thy- 
roid-stimulating antibody levels were reduced. 
The relationship between hypothyroidism and MG has 
been studied by Feinberg, Underdahl, and Eaten. »Drach- 
man 6 reported that aggravation of MG occurs in patients 
with both MG and euthyroid thyroid disease when func- 
tion becomes either hyperthyroid or hypothyroid. Ours is 
a rare case in which the onset of MG coincided with the 
transformation f hyperthyroid to hypothyroid isease. It 
is ditticult to assess the effect of thymectomy on thyroid 
function. TSH-binding inhibitory immunoglobulin and 
thyroid-stimulating antibody values clearly decreased af- 
ter thymectomy. This observation suggests that the thymus 
also plays a role in the pathophysiology of autoimmune 
thyroid diseases. 
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